LyondellBasell Plunges to $890M Loss on Massive Impairments

Ticker: LYB · Form: 10-Q · Filed: 2025-10-31T00:00:00.000Z

Sentiment: bearish

Topics: Chemicals, Polymers, Refining, Impairments, Asset Sales, Net Loss, European Market

Related Tickers: LYB, DD, CE, EMN

TL;DR

**LYB's massive impairments and European asset sale signal a tough quarter and a strategic pivot, making it a risky bet for now.**

AI Summary

LyondellBasell Industries N.V. (LYB) reported a significant net loss of $890 million for the three months ended September 30, 2025, a stark contrast to the net income of $573 million in the prior-year period. For the nine months ended September 30, 2025, the company posted a net loss of $598 million, compared to a net income of $1,970 million in the same period of 2024. This downturn was primarily driven by substantial goodwill impairments of $972 million and other impairments of $230 million in the third quarter of 2025. Sales and other operating revenues decreased to $7,727 million for the three months ended September 30, 2025, from $8,604 million in the comparable 2024 period. The company also ceased operations at its Houston refinery in February 2025, reclassifying it as a discontinued operation. Furthermore, LYB entered into an agreement in June 2025 to sell select olefins & polyolefins assets in Europe, expecting to recognize a loss on sale of approximately $700 million to $900 million upon closing in the first half of 2026.

Why It Matters

This significant net loss and the substantial impairment charges signal a challenging operating environment for LyondellBasell, particularly within its European olefins & polyolefins segment. For investors, this indicates potential headwinds and a re-evaluation of the company's asset base, impacting future profitability and dividend sustainability. Employees at the divested European sites face uncertainty, while customers might see shifts in supply chains. Competitively, this move suggests a strategic retreat from less profitable European operations, potentially allowing rivals to gain market share or for LYB to focus on more robust regions.

Risk Assessment

Risk Level: high — The company reported a net loss of $890 million for the three months ended September 30, 2025, primarily due to $972 million in goodwill impairments and $230 million in other impairments. This, coupled with an expected loss on sale of $700 million to $900 million from European asset divestitures, indicates significant asset value erosion and operational challenges.

Analyst Insight

Investors should exercise caution and thoroughly review LyondellBasell's strategic rationale for the European asset sales and the impact of these impairments on future earnings. Consider holding off on new investments until there's clearer guidance on how the company plans to restore profitability and what the long-term implications of these divestitures are for its core business.

Financial Highlights

revenue
$7,727M
net Income
$(890)M
eps
$(2.77)
revenue Growth
-10.1%

Revenue Breakdown

SegmentRevenueGrowth
Trade$7,585M-10.1%
Related parties$142M-12.3%

Key Numbers

Key Players & Entities

FAQ

What caused LyondellBasell's significant net loss in Q3 2025?

LyondellBasell reported a net loss of $890 million for the three months ended September 30, 2025, primarily due to $972 million in goodwill impairments and $230 million in other impairments recognized during the period.

How did LyondellBasell's revenue perform in the third quarter of 2025?

Sales and other operating revenues for LyondellBasell decreased to $7,727 million for the three months ended September 30, 2025, down from $8,604 million in the comparable period of 2024.

What strategic changes did LyondellBasell make regarding its refining business?

LyondellBasell ceased business operations at its Houston refinery in February 2025. Consequently, its refining business is now reported as a discontinued operation for all periods presented.

What is the expected financial impact of LyondellBasell's European asset sale?

LyondellBasell expects to recognize a loss on the sale of its select European olefins & polyolefins assets of approximately $700 million to $900 million upon closing, which is anticipated in the first half of 2026.

When is the closing of LyondellBasell's European asset sale expected?

The closing of the proposed transaction for the sale of select European olefins & polyolefins assets is currently expected in the first half of 2026, subject to customary closing and regulatory conditions.

How much did LyondellBasell spend on common stock dividends in the nine months ended September 30, 2025?

LyondellBasell paid $1,321 million in common stock dividends, or $4.08 per share, for the nine months ended September 30, 2025.

What was LyondellBasell's cash position at the end of Q3 2025?

As of September 30, 2025, LyondellBasell reported cash and cash equivalents of $1,784 million, a decrease from $3,375 million at December 31, 2024.

What is the status of LyondellBasell's assets held for sale?

As of September 30, 2025, LyondellBasell classified $802 million in assets as held for sale, related to the agreement for the sale of select olefins & polyolefins assets and associated business in Europe.

What new accounting guidance will LyondellBasell adopt in 2025?

LyondellBasell will adopt the new guidance for Income Tax Disclosures (ASU 2023-09) in the 2025 annual period, which requires additional disclosures about specific categories in the rate reconciliation and net income taxes paid or received.

What was LyondellBasell's basic loss per share from continuing operations in Q3 2025?

LyondellBasell's basic loss per share from continuing operations was $(2.58) for the three months ended September 30, 2025, compared to earnings per share of $1.92 in the prior-year period.

Risk Factors

Industry Context

LyondellBasell operates in the highly competitive petrochemical industry, which is cyclical and sensitive to global economic conditions and feedstock prices. Key industry trends include increasing demand for sustainable materials, consolidation through mergers and acquisitions, and evolving regulatory landscapes concerning environmental impact and chemical production.

Regulatory Implications

The company faces ongoing regulatory scrutiny related to environmental compliance, emissions standards, and chemical safety. Changes in environmental regulations, particularly in Europe and North America, could impact operational costs and require significant capital investments for compliance.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Key Dates

Glossary

Goodwill impairments
A reduction in the carrying value of goodwill on the balance sheet when its fair value is determined to be less than its carrying amount. Goodwill arises from acquisitions. (A significant $972 million goodwill impairment charge in Q3 2025 was a primary driver of the company's net loss.)
Discontinued operations
A component of a business that the reporting entity has disposed of or classified as held for sale, and that represents a separate major line of business or geographical area of operations. (The Houston refinery was reclassified as discontinued operations, affecting how its results are presented.)
Olefins & polyolefins
Olefins (like ethylene and propylene) are basic building blocks for plastics, and polyolefins are polymers made from these olefins, forming a major segment of the petrochemical industry. (The planned sale of these assets in Europe indicates a strategic shift away from or restructuring of this business segment.)
Net loss
The total expenses of a company exceed its total revenues over a specific period. (LyondellBasell reported a substantial net loss of $890 million for Q3 2025, a significant negative financial outcome.)

Year-Over-Year Comparison

LyondellBasell has experienced a significant downturn in financial performance compared to the prior year. For the three months ended September 30, 2025, the company reported a net loss of $890 million, a sharp contrast to the $573 million net income in the same period of 2024. Sales and other operating revenues also declined to $7,727 million from $8,604 million year-over-year. The current period's results were heavily impacted by substantial impairment charges totaling $1,102 million ($972M goodwill and $230M other), which were not present in the prior year, leading to an operating loss of $731 million compared to an operating income of $865 million.

Filing Stats: 4,852 words · 19 min read · ~16 pages · Grade level 13.3 · Accepted 2025-10-31 13:24:24

Filing Documents

– Financial Information

Part I – Financial Information 1

Consolidated Financial Statements (Unaudited)

Item 1. Consolidated Financial Statements (Unaudited) 1 Consolidated Statements of (Loss) I ncome 1 Consolidated Statements of Comprehensive ( Loss ) I ncome 2 Consolidated Balance Sheets 3 Consolidated Statements of Cash Flows 5 Consolidated Statements of Shareholders' Equity 7 Notes to the Consolidated Financial Statements 9

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 33

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 49

Controls and Procedures

Item 4. Controls and Procedures 50

– Other Information

Part II – Other Information 51

Legal Proceedings

Item 1. Legal Proceedings 51

Risk Factors

Item 1A. Risk Factors 51

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 51

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 51

Other Information

Item 5. Other Information 51

Exhibits

Item 6. Exhibits 52 Signature 53 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) LYONDELLBASELL INDUSTRIES N.V. CONSOLIDATED STATEMENTS OF (LOSS) INCOME Three Months Ended September 30, Nine Months Ended September 30, Millions of dollars, except earnings per share 2025 2024 2025 2024 Sales and other operating revenues: Trade $ 7,585 $ 8,442 $ 22,616 $ 25,096 Related parties 142 162 446 490 7,727 8,604 23,062 25,586 Operating costs and expenses: Cost of sales 6,821 7,303 20,820 21,747 Goodwill impairments 972 — 972 — Other impairments 230 5 262 5 Selling, general and administrative expenses 401 400 1,237 1,223 Research and development expenses 34 31 103 96 8,458 7,739 23,394 23,071 Operating (loss) income ( 731 ) 865 ( 332 ) 2,515 Interest expense ( 130 ) ( 118 ) ( 355 ) ( 365 ) Interest income 21 36 72 114 (Loss) gain on sale of business ( 6 ) — ( 6 ) 293 Other (expense) income, net ( 2 ) 14 48 28 (Loss) income from continuing operations before equity investments and income taxes ( 848 ) 797 ( 573 ) 2,585 Loss from equity investments ( 8 ) ( 20 ) — ( 66 ) (Loss) income from continuing operations before income taxes ( 856 ) 777 ( 573 ) 2,519 (Benefit from) provision for income taxes ( 27 ) 151 78 514 (Loss) income from continuing operations ( 829 ) 626 ( 651 ) 2,005 (Loss) income from discontinued operations, net of tax ( 61 ) ( 53 ) 53 ( 35 ) Net (loss) income ( 890 ) 573 ( 598 ) 1,970 Dividends on redeemable non-controlling interests ( 2 ) ( 2 ) ( 5 ) ( 5 ) Net (loss) income attributable to the Company shareholders $ ( 892 ) $ 571 $ ( 603 ) $ 1,965 (Loss) earnings per share: Net (loss) income attributable to the Company shareholders — Basic Continuing operations $ ( 2.58 ) $ 1.92 $ ( 2.05 ) $ 6.13 Discontinued operations ( 0.19 ) ( 0.16 ) 0.16 ( 0.11 ) $ ( 2.77 ) $ 1.76 $ ( 1.89 ) $ 6.02 Diluted Continuing operations $ ( 2.58 ) $ 1.91 $ ( 2.05 ) $ 6.11 Discontinued operations ( 0.19 ) ( 0.16 ) 0.16 ( 0.11 ) $ ( 2.77 ) $ 1.75 $ ( 1.89 ) $ 6.00 See

View on Read The Filing